Moderate to Severe Crohn's Disease
Immunology·MeSH: Crohn Disease
Prevalence
201.0 / 100K
Incidence
6.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| AZD7798 | ASTRAZENECA PLC (AZN) |
Frequently asked questions
How many drugs are in development for Moderate to Severe Crohn's Disease?
BioSniper tracks 1 drug in development for Moderate to Severe Crohn's Disease across 1 company.
How many clinical trials target Moderate to Severe Crohn's Disease?
There are 1 clinical trial targeting Moderate to Severe Crohn's Disease tracked by BioSniper.
What is the prevalence of Moderate to Severe Crohn's Disease?
The estimated prevalence of Moderate to Severe Crohn's Disease is approximately 201.0 per 100,000 population.
Deep-dive into Moderate to Severe Crohn's Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis